Sale!

HLA Pre-Transplant Workup Sensitized Recipient Panel 4 Test Cost

Original price was: 4,290 د.إ.Current price is: 3,860 د.إ.

-10%

The “HLA Pre-Transplant Workup Sensitized Recipient Panel 4 Test” is a critical diagnostic procedure conducted before organ transplantation to ensure compatibility between the donor and the recipient. This test is particularly essential for recipients who are considered sensitized, meaning they have developed antibodies against potential donor HLA (Human Leukocyte Antigen) types due to previous transplants, blood transfusions, or pregnancies. The presence of these antibodies can significantly increase the risk of transplant rejection.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test meticulously analyzes the recipient’s blood for specific HLA antibodies that could react against the donor’s organ. By identifying these antibodies, healthcare providers can make informed decisions on the suitability of a potential donor, thereby increasing the chances of transplant success and longevity of the transplanted organ.

The cost of the “HLA Pre-Transplant Workup Sensitized Recipient Panel 4 Test” at DNA Labs UAE is 3860 AED. This investment is crucial for sensitized recipients, as it provides a detailed risk assessment that guides the transplant team in selecting the most compatible donor, ultimately contributing to a better outcome for the recipient.

Description

HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4 Test

Test cost: AED 3860.0

Test Components:

Donor: HLA DNA High resolution Typing, NGS

Price: 3860.0 AED

Sample Condition:

DONOR: 12 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes
4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube
4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube
Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE.

Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Report Delivery: 10-12 days

Method:

Complement Dependent Cytotoxicity with DTT treatment
Reverse SSOP – Luminex
Luminex X-Map technology
Flow cytometry
Sequence based Typing (SBT)

Test type: Transplantation

Doctor: Nephrologist

Test Department:

Pre Test Information:

Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.

Test Details:

The HLA pre-transplant workup sensitized recipient panel 4 test is a specific test that is conducted before a solid organ transplant (such as kidney, liver, heart, or lung transplant) to determine the level of sensitization of the potential recipient. The test specifically looks at the sensitization of the recipient to human leukocyte antigens (HLAs). HLAs are proteins found on the surface of cells that play a critical role in the immune response. When a person is sensitized to HLAs, it means that their immune system has been exposed to these antigens, often through previous blood transfusions, pregnancies, or previous organ transplants.

The sensitized recipient panel 4 test measures the presence of antibodies in the recipient’s blood that are specific to HLAs. The test is usually performed using a technique called flow cytometry or solid-phase assays. By identifying the specific HLAs to which the recipient is sensitized, healthcare providers can better assess the potential risk of rejection and compatibility for organ transplantation.

Based on the results of the test, healthcare providers can determine the best course of action for the transplant, such as finding a suitable donor organ that matches the recipient’s HLA profile or considering additional interventions, such as desensitization therapies, to reduce the level of sensitization and improve the chances of a successful transplant.

Test Name	HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4 Test
Components	Donor: *HLA DNA High resolution Typing, NGS
Price	3860.0 AED
Sample Condition	DONOR: 12 mL (10 mL min.) whole blood in 2 Yellow Top (ACD) tubes AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tubeAND4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE.Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery	10-12 days
Method	Complement Dependent Cytotoxicity with DTT treatment, Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry, Sequence based Typing (SBT)
Test type	Transplantation
Doctor	Nephrologist
Test Department:
Pre Test Information	Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details	The HLA pre-transplant workup sensitized recipient panel 4 test is a specific test that is conducted before a solid organ transplant (such as kidney, liver, heart, or lung transplant) to determine the level of sensitization of the potential recipient. The test specifically looks at the sensitization of the recipient to human leukocyte antigens (HLAs). HLAs are proteins found on the surface of cells that play a critical role in the immune response. When a person is sensitized to HLAs, it means that their immune system has been exposed to these antigens, often through previous blood transfusions, pregnancies, or previous organ transplants. The sensitized recipient panel 4 test measures the presence of antibodies in the recipient’s blood that are specific to HLAs. The test is usually performed using a technique called flow cytometry or solid-phase assays. By identifying the specific HLAs to which the recipient is sensitized, healthcare providers can better assess the potential risk of rejection and compatibility for organ transplantation. Based on the results of the test, healthcare providers can determine the best course of action for the transplant, such as finding a suitable donor organ that matches the recipient’s HLA profile or considering additional interventions, such as desensitization therapies, to reduce the level of sensitization and improve the chances of a successful transplant.